Confirma Appoints New Vice President of Sales.

BELLEVUE, Wash. -- Confirma, leader in computer-aided-detection (CAD) for medical imaging, announced today that it has appointed Ward Sparacio as Vice President of Sales. Ward will report to Dan Bickford, Executive Vice President of Sales and Marketing.

"We are pleased to welcome Ward to our executive team," said Wayne Wager, President and CEO of Confirma. "Ward has a strong track record in medical imaging sales management and will contribute to making Confirma a leader in the CAD market."

Prior to joining Confirma, Ward Sparacio was director of sales for SonoSite, a leading manufacturer of ultrasound equipment. At SonoSite, Ward was responsible for leading a field sales team of more than 100 staff members. Ward managed SonoSite's 100 million dollar domestic sales organization, as well as clinical operations and administrative functions. Ward also served as director of corporate business development where he managed relationships with industry Group Purchasing Organizations and Integrated Health Networks. Ward earned his BS degree in Biology from Pacific Union College.

About Breast MRI and CADstream

The ACS panel on breast cancer screening now recommends that women with a 20-25 percent or greater lifetime risk of the disease undergo an annual MRI in addition to mammography. In addition to the new ACS guidelines, a study published in the New England Journal of Medicine suggests that women with cancer found in one breast should undergo an MRI scan of the other breast.

Due to the recent news and published clinical studies supporting breast MRI for increased breast cancer detection, it is becoming increasingly important to improve analysis of these complex, time-consuming studies. CADstream is intuitive technology that is advancing breast MRI by enhancing accuracy, standardization and efficiency of studies. The system automates analysis, reporting and interventional planning of studies and promotes standardization with the incorporation of the ACR BI-RADS([R]) Atlas. CADstream was first introduced at the Radiological Society of North America (RSNA) meeting in 2002 and is currently in use by thousands of physician users and hundreds of breast MRI programs.

About Confirma, Inc.

Confirma, Inc. develops and markets CAD systems and accessories for medical imaging. CADstream[TM] is the standard in CAD for magnetic resonance imaging (MRI). CADstream[TM] automates the analysis and interventional guidance of MRI studies, providing higher quality imaging studies, lower costs for radiology practices and improved communication tools for physicians and patients. In its initial application, CADstream[TM] is being used to assist in the analysis, interventional guidance and reporting of breast MRI studies. CADstream[TM] is DICOM 3.0 compliant, allowing integration with any MRI scanner and PACS. The company plans to adapt its proven CAD technology to advance other medical imaging applications.

Confirma has established partnerships with companies including GE Healthcare, Philips Medical Systems, Bayer HealthCare, Medipattern, Vital Images and CARESTREAM. Confirma has partnered with hundreds of imaging centers and corporate partners worldwide since 2003, helping develop more standardized, high performance breast MRI programs that deliver premium patient care. Confirma Europe GmbH opened operations in Berlin to further develop the European market. Frost & Sullivan recently recognized Confirma with the 2006 Industry Innovation and Advancement Award for the U.S. CAD market. For more information, visit www.confirma.com or call 877-811-2356.